Debiopharm Innovation Fund — Pre-Seed & Seed VC Firm
Debiopharm Innovation Fund is a Pre-Seed, Seed, Series A venture capital firm based in Lausanne, Switzerland investing in Healthcare, Other, AI / ML. The firm has 30 portfolio companies in our records.
- Portfolio
- 30 companies on record
- Partners
- 11 listed
- Stage
- Pre-Seed, Seed, Series A
- Sectors
- Healthcare, Other, AI / ML
- HQ
- Lausanne, Switzerland
- Check size
- Not in our records
- AUM
- Not in our records
Last verified: 2026-10-14
Pre-Seed, Seed, Series A
30+ companies
11 partners
Investment Thesis
Strategic investment arm with a long-running focus on digital health, now adding earlier seed investing. Emphasis includes advancing digital innovation in healthcare and transforming pharmaceutical R&D.
How Debiopharm Innovation Fund invests
Debiopharm Innovation Fund is a vc firm based in Lausanne, Switzerland. The firm invests at the Pre-Seed, Seed, Series A stages, with a focus on Healthcare, Other, AI / ML.
Debiopharm Innovation Fund has backed 30 companies in our records, including Stitch, ModernVivo, StratifAI.
Partners & Team
Fabrice Paradies
Director
Maurice Wagner
Director Corporate Affairs
Unknown
GP
Industry Focus
Invests In
Portfolio Companies (30)
Other
Stitch
Streamlining clinical trial sites operations while improving patient engagement and experience
ModernVivo
AI-driven platform transforming in vivo study design for smarter and faster research
StratifAI
Multimodal artificial intelligence models for prognostic insights from routinely available histology images and clinical data.
Tune Insight
A privacy-preserving data collaboration platform
Genialis
Biomarker discovery and patient identification for clinical trials
Altis Labs
AI-powered computational imaging company advancing precision medicine
VerisimLife
A computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials.
Mekonos
Novel ex vivo cell engineering platform for cell therapies
Oncomfort
A start-up in digital therapy for pain and anxiety management
Voluntis
A leader in the field of digital therapeutics
- •Raising at Pre-Seed, Seed, Series A? You're squarely in their sweet spot.
- •Lead with your fit in Healthcare, Other, AI / ML — the sectors they actively back.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Olivier Cochet, Director of Pharmaceutical Development.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if Debiopharm Innovation Fund is a match for your startup
Upload your pitch deck to see how well you match with Debiopharm Innovation Fund and 10,000+ other investors.
Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT
Is this your profile? Request a correction or removal